• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Systematic review and meta-analysis of olfactory and gustatory dysfunction in coronavirus disease 2019

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2022 Feb 5;S1201-9712(22)00079-0.
doi: 10.1016/j.ijid.2022.02.004. Online ahead of print.
Systematic review and meta-analysis of olfactory and gustatory dysfunction in coronavirus disease 2019


Nanyang Liu[SUP] 1 [/SUP], Di Yang[SUP] 2 [/SUP], Tingting Zhang[SUP] 3 [/SUP], Jiahui Sun[SUP] 4 [/SUP], Jianhua Fu[SUP] 5 [/SUP], Hao Li[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Chemosensory disorders associated with coronavirus disease 2019 (COVID-19) have been widely mentioned during the pandemic. We performed a meta-analysis to assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19.
Methods: Three databases (PubMed, Embase, and Cochrane Library) were searched for studies published between December 1st, 2019 to August 31st, 2021. Select random effects model or fixed effects model to pool data based on heterogeneity. The results were reported as odds ratios or standardized mean differences and the corresponding 95% confidence intervals. Heterogeneity was reported as I[SUP]2[/SUP].
Results: Twenty-six studies with a total of 13813 patients were included. The pooled data indicated that sex (OR, 1.47; 95% CI, 0.93-2.31), age (SMD, -5.80; 95% CI, -13.35-1.75), smoking (OR, 2.04; 95% CI, 0.72-5.79), and comorbidity (OR, 1.21; 95% CI, 0.58-2.53) of COVID-19 patients had no effect on gustatory dysfunction. Olfactory dysfunction was more likely to occur in elderly patients with COVID-19 (SMD, -5.22; 95% CI, -8.28- -2.16). And COVID-19 patients with nasal congestion (OR, 3.41;95%CI, 2.30-5.06) and rhinorrhea (OR, 2.35; 95%CI, 1.60-3.45) are more prone to olfactory dysfunction.
Conclusion: These findings emphasize that elderly COVID-19 patients are more likely to suffer from olfactory dysfunction. Symptoms of nasal congestion and rhinorrhea may affect the recognition of olfactory dysfunction.

Keywords: ARS-CoV-2; COVID-19; chemosensory disorders; gustatory dysfunction; olfactory dysfunction; systematic review and meta-analysis.
 
Back
Top Bottom